Adding cagrilintide to tirzepatide Theoretical protocol (not clinically studied): If on tirzepatide 10-15mg: Stable on tirzepatide for 4+ weeks Continue tirzepatide at current dose Add cagrilintide 0.6mg weekly Standard cagrilintide titration to 2.4mg Rationale: Tirzepatide is dual GIP/GLP-1 (very powerful alone) Adding amylin pathway could theoretically enhance No clinical data on this combination Uncertain if additional benefit over tirzepatide alone Concerns: GI side effects may be severe (both slow gastric emptying) Tirzepatide already produces 15-22% weight loss alone Unclear if cagrilintide adds meaningful benefit Expensive combination Verdict: Wait for clinical data
Research does show GHK-Cu: Stimulates collagen and glycosaminoglycan production Improves wound healing in laboratory and clinical settings Reduces inflammation and oxidative stress Supports healthier skin structure over time These effects are well documented in scientific literature, especially in wound care and tissue repair contexts
Animal models: Nanoliposome-encapsulated GHK-Cu showed accelerated hair growth in C57BL/6 mice with visibly earlier anagen onset compared to free peptide controls (Tian et al., 2022)
Its quick, potent, and often marketed as the ultimate antioxidant boost
Studies suggest this approach can achieve tissue concentrations approaching injectable levels
It stimulates fibroblast and keratinocyte proliferation, aiding re-epithelialization and ECM remodeling
